Barclays Maintains Overweight on Elanco Animal Health, Raises Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad has maintained an Overweight rating on Elanco Animal Health (ELAN) and increased the price target from $18 to $19.
February 27, 2024 | 2:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has maintained an Overweight rating on Elanco Animal Health and raised the price target from $18 to $19.
The upgrade in the price target by a reputable analyst like Balaji Prasad from Barclays indicates a positive outlook on ELAN's stock. Such endorsements often lead to increased investor confidence and can drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100